Command Palette

Search for a command to run...

BIOFILCHEM

40.8-0.95%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

In the Pharmaceuticals & Drugs sector, companies like Sun Pharmaceutical Industries and Cipla stand out with strong profitability and growth metrics, while Biofil Chemicals & Pharmaceuticals Ltd. is significantly underperforming with zero growth and profitability. The sector showcases a mix of strong performers and financially stressed companies, with several undervalued opportunities.

Key Points
  • Biofil Chemicals shows zero revenue growth and profitability metrics, indicating serious financial distress.
  • Sun Pharmaceutical leads in profitability with a high ROE and consistent revenue growth.
  • Cipla is the most attractive in terms of valuation with a low PE ratio and strong EPS growth.
  • Divi's Laboratories has a high PEG, indicating potential overvaluation despite decent growth metrics.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest profitability with a ROE of 16.13% and consistent revenue growth of 8.42% YoY.

Cipla Ltd.

Best valuation attractiveness with a PE ratio of 23.73 and strong revenue growth of 13.28% YoY.

Dr. Reddy's Laboratories Ltd.

High profitability with a ROE of 21.76% and strong EPS growth.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.